Analysts are starting to pile into the biotech bandwagon now. And for good reason: the AMEX Biotech Index is actually lower today than it was nine years ago.  Translated into investor-speak, the opportunities in biotech today are fantastic.

I’m not a biotech guy, but my fellow analyst Marc Lichtenfeld is, and he writes about them regularly.

Now that Investment U and our sister publication – Smart Profits – are combining forces, you’ll be hearing about the biotech sector from Marc on a regular basis. Nevertheless, there is something that I do know about the healthcare and biotech sector.

All biotech companies – regardless of whether or not they turn out to be a good investment – need laboratory services and equipment. Therefore, it stands to reason that any boom in the biotech sector would drag along these companies for the ride.

Becton Dickson and Company (NYSE: BDX) – a large-cap

...

Becton Dickson and Company (NYSE: BDX): Stock of the Day

by David Fessler, Advisory Panelist

Analysts are starting to pile into the biotech bandwagon now. And for good reason: the AMEX Biotech Index is actually lower today than it was nine years ago.

Translated into investor-speak, the opportunities in biotech today are fantastic. I’m not a biotech guy, but my fellow analyst Marc Lichtenfeld is, and he writes about them regularly.

Now that Investment U and our sister publication – Smart Profits – are combining forces, you’ll be hearing about the biotech sector from Marc on a regular basis. Nevertheless, there is something that I do know about the healthcare and biotech sector.

All biotech companies – regardless of whether or not they turn out to be a good investment – need laboratory services and equipment.

...

Becton, Dickinson and Company (BDX) keeps seeing bullish forecasts on strong fundamentals as the company prepares to report early next week. Analysts are projecting earnings growth of 10.5% for the fiscal year ending September 2009 followed by growth of 10.5% more in fiscal 2010.

< ?DART(15);?> Company Description

Becton, Dickinson and Company is a medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines.

Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

Solid Fundamentals

Becton, Dickinson and Company's return on equity (ROE) of 24% tops

...

Becton, Dickinson and Company (BDX) continues to see bullish forecasts from Wall Street. Analysts are projecting earnings growth of 10% for the fiscal year ending September 2009 followed by growth of 10% more in fiscal 2010.

< ?DART(15);?> Company Description

Becton, Dickinson and Company is a medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines.

Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

A Recent Dividend

In early February, the company declared a quarterly dividend of 33 cents per share, which was paid out on

...

Today after the bell, Performance Health Techonlogies announced that CEO Robert D. Prunetti joined the company’s sales, marketing and distribution partner, Interactive Metronome (IM), for a two-day sales conference in Fort Lauderdale, Florida. While at the conference, they demonstrated the company’s Core:Tx® rehabilitation technology to gather important feedback, which will be used to launch a marketing and sales initiative planned for the current quarter of this year.

This initiative, cleverly titled “Movement,” will use information gathered from ‘pilot trials’ at rehabilitation centers, in-service training sessions with rehab professionals, and sales presentations to improve sales techniques. Movement will also assist with developing certification courses for Core:Tx®, enhancing software design for easier use, and identifying greater opportunities for sales.

Core:Tx is a unique system that turns rehabilitation therapy into a game-like experience. The wireless system enhances patients’ recovery from neuromuscular conditions by adding an element of entertainment

...